202 related articles for article (PubMed ID: 30714145)
1. Inhibition of Ca
Picard E; Carvalho FA; Agosti F; Bourinet E; Ardid D; Eschalier A; Daulhac L; Mallet C
Br J Pharmacol; 2019 Apr; 176(7):950-963. PubMed ID: 30714145
[TBL] [Abstract][Full Text] [Related]
2. Colonic overexpression of the T-type calcium channel Ca
Scanzi J; Accarie A; Muller E; Pereira B; Aissouni Y; Goutte M; Joubert-Zakeyh J; Picard E; Boudieu L; Mallet C; Gelot A; Ardid D; Carvalho FA; Dapoigny M
Neurogastroenterol Motil; 2016 Nov; 28(11):1632-1640. PubMed ID: 27196538
[TBL] [Abstract][Full Text] [Related]
3. Essential role of Ca
Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
Eur J Pharmacol; 2020 Nov; 887():173576. PubMed ID: 32949597
[TBL] [Abstract][Full Text] [Related]
4. T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome.
Marger F; Gelot A; Alloui A; Matricon J; Ferrer JF; Barrère C; Pizzoccaro A; Muller E; Nargeot J; Snutch TP; Eschalier A; Bourinet E; Ardid D
Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11268-73. PubMed ID: 21690417
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of α2δ-1 ligands in mouse models of colonic hypersensitivity.
Meleine M; Boudieu L; Gelot A; Muller E; Lashermes A; Matricon J; Silberberg C; Theodorou V; Eschalier A; Ardid D; Carvalho FA
World J Gastroenterol; 2016 Aug; 22(31):7111-23. PubMed ID: 27610021
[TBL] [Abstract][Full Text] [Related]
6. State-dependent properties of a new T-type calcium channel blocker enhance Ca(V)3.2 selectivity and support analgesic effects.
Francois A; Kerckhove N; Meleine M; Alloui A; Barrere C; Gelot A; Uebele VN; Renger JJ; Eschalier A; Ardid D; Bourinet E
Pain; 2013 Feb; 154(2):283-293. PubMed ID: 23257507
[TBL] [Abstract][Full Text] [Related]
7. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
[TBL] [Abstract][Full Text] [Related]
8. Peripheral contribution of NGF and ASIC1a to colonic hypersensitivity in a rat model of irritable bowel syndrome.
Matricon J; Muller E; Accarie A; Meleine M; Etienne M; Voilley N; Busserolles J; Eschalier A; Lazdunski M; Bourdu S; Gelot A; Ardid D
Neurogastroenterol Motil; 2013 Nov; 25(11):e740-54. PubMed ID: 23902154
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice.
Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849
[TBL] [Abstract][Full Text] [Related]
10. Multiple roles for NaV1.9 in the activation of visceral afferents by noxious inflammatory, mechanical, and human disease-derived stimuli.
Hockley JR; Boundouki G; Cibert-Goton V; McGuire C; Yip PK; Chan C; Tranter M; Wood JN; Nassar MA; Blackshaw LA; Aziz Q; Michael GJ; Baker MD; Winchester WJ; Knowles CH; Bulmer DC
Pain; 2014 Oct; 155(10):1962-75. PubMed ID: 24972070
[TBL] [Abstract][Full Text] [Related]
11. Role of T CD4
Picard E; Kerckhove N; François A; Boudieu L; Billard E; Carvalho FA; Bogard G; Gosset P; Bourdier J; Aissouni Y; Bourinet E; Eschalier A; Daulhac L; Mallet C
Br J Pharmacol; 2023 Feb; 180(4):385-400. PubMed ID: 36131381
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
[TBL] [Abstract][Full Text] [Related]
13. Analgesic transient receptor potential vanilloid-1-active compounds inhibit native and recombinant T-type calcium channels.
McArthur JR; Finol-Urdaneta RK; Adams DJ
Br J Pharmacol; 2019 Jul; 176(13):2264-2278. PubMed ID: 30927254
[TBL] [Abstract][Full Text] [Related]
14. Ethosuximide improves chronic pain-induced anxiety- and depression-like behaviors.
Kerckhove N; Boudieu L; Ourties G; Bourdier J; Daulhac L; Eschalier A; Mallet C
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1419-1432. PubMed ID: 31767519
[TBL] [Abstract][Full Text] [Related]
15. Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome.
Fuentes IM; Christianson JA
Neurogastroenterol Motil; 2016 Nov; 28(11):1613-1618. PubMed ID: 27781369
[TBL] [Abstract][Full Text] [Related]
16. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
Castro J; Harrington AM; Hughes PA; Martin CM; Ge P; Shea CM; Jin H; Jacobson S; Hannig G; Mann E; Cohen MB; MacDougall JE; Lavins BJ; Kurtz CB; Silos-Santiago I; Johnston JM; Currie MG; Blackshaw LA; Brierley SM
Gastroenterology; 2013 Dec; 145(6):1334-46.e1-11. PubMed ID: 23958540
[TBL] [Abstract][Full Text] [Related]
17. NaV1.1 inhibition can reduce visceral hypersensitivity.
Salvatierra J; Castro J; Erickson A; Li Q; Braz J; Gilchrist J; Grundy L; Rychkov GY; Deiteren A; Rais R; King GF; Slusher BS; Basbaum A; Pasricha PJ; Brierley SM; Bosmans F
JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875317
[TBL] [Abstract][Full Text] [Related]
18. Identification of interleukin-1 beta as a key mediator in the upregulation of Cav3.2-USP5 interactions in the pain pathway.
Stemkowski PL; Garcia-Caballero A; Gadotti VM; M'Dahoma S; Chen L; Souza IA; Zamponi GW
Mol Pain; 2017; 13():1744806917724698. PubMed ID: 28741432
[TBL] [Abstract][Full Text] [Related]
19. Effect of ABT-639 on Cav3.2 channel activity and its analgesic actions in mouse models of inflammatory and neuropathic pain.
Antunes FTT; Huang S; Chen L; Zamponi GW
Eur J Pharmacol; 2024 Mar; 967():176416. PubMed ID: 38342359
[TBL] [Abstract][Full Text] [Related]
20. Myogenic tone is impaired at low arterial pressure in mice deficient in the low-voltage-activated CaV 3.1 T-type Ca(2+) channel.
Björling K; Morita H; Olsen MF; Prodan A; Hansen PB; Lory P; Holstein-Rathlou NH; Jensen LJ
Acta Physiol (Oxf); 2013 Apr; 207(4):709-20. PubMed ID: 23356724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
